Has Rosario Guarino received payments from drug or device companies?

Yes. Drug and device makers reported $1,989 in general payments to Rosario Guarino across 134 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rosario Guarino did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rosario Guarino come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rosario Guarino

Neurology · Rocky Mount, NCNPI 1255431516

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $947 and has fallen 88.1% since, to $113 in 2023.

$1,989in general payments, 2019–2025

Across 134 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$417
Sunovion Pharmaceuticals Inc.$257
Novartis$152
Amneal Pharmaceuticals LLC$119
Teva Pharmaceuticals USA, Inc.$108
Amgen$96
plus $840 from 23 others

What the payments were for

Speaking & faculty fees$352%
Food & beverage$1,95598%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	34	$417
Sunovion Pharmaceuticals Inc.	19	$257
Novartis	10	$152
Amneal Pharmaceuticals LLC	8	$119
Teva Pharmaceuticals USA, Inc.	8	$108
Amgen	4	$96
Supernus Pharmaceuticals, Inc.	6	$80
MDD US Operations, LLC	5	$71
Acadia Pharmaceuticals Inc	5	$65
Biohaven Pharmaceutical Holding Company Ltd.	3	$55
Avanir Pharmaceuticals, Inc.	3	$53
AstraZeneca	3	$50
Grifols USA, LLC	2	$44
Shire North American Group Inc	3	$42
Mallinckrodt Enterprises LLC	2	$41
Vertical Pharmaceuticals, LLC	2	$38
Tanabe Pharma America, Inc.	2	$37
Acorda Therapeutics, Inc	2	$35
Bausch Health US, LLC	2	$34
UCB, Inc.	2	$31
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$24
Sumitomo Pharma America, Inc.	1	$23
SK Life Science, Inc.	1	$21
GE HealthCare	1	$20
Assertio Therapeutics, Inc.	1	$19
Biogen	1	$17
Novo Nordisk	1	$15
Pfizer	1	$14
Adamas Pharmaceuticals, Inc.	1	$11

How this compares

$1,989 in reported general payments places this provider in the 60th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina →

Other neurology in Rocky Mount

Jill ConwayCharlotte$1M
Matthew CarraroCharlotte$695K
Richard SaterGreensboro$682K
Sara SaccoMatthews$651K
Megan DonnellyCharlotte$601K
Kevin KahnDurham$587K
Sanjay IyerCharlotte$581K
Mark SkeenDurham$562K
Douglas JefferyMooresville$486K
John ScagnelliRaleigh$429K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →